I
Immunovant, Inc. (IMVT)
NMS – Real Time Price. Currency in USD
38.85
+0.61 (1.60%)
At close: Jun 26, 2026, 4:00 PM EDT
38.84
-0.01 (-0.03%)
After-hours: Jun 26, 2026, 5:32 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
38.85
+0.61 (1.60%)
At close: Jun 26, 2026, 4:00 PM EDT
38.84
-0.01 (-0.03%)
After-hours: Jun 26, 2026, 5:32 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $902.1M significantly exceed its total debt $72.0K, ensuring strong financial flexibility
Total current assets $948.8M exceed Total current liabilities $104.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$95.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 9.09 | 6.05 | 10 | |
| Quick ratio | 9.09 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -1M | -231K | -377K | -409K | -409K |
| Operating Income | -208M | -270M | -438M | -533M | -533M |
| Net Income | -211M | -259M | -414M | -506M | -506M |
| EBITDA | -207M | -270M | -438M | -532M | -532M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 14.86 | 4.5 |
| Next quarter | N/A | 14.37 | 4.5 |
| Current year | N/A | 5.5 | 3.0 |
| Next year | N/A | 3.09 | 2.5 |
| Weighted average score | 3.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -33.63 | -19.66 | -2.96 | 3.3 |
| Y/Y | 999 | -38.89 | -14.05 | 14.23 | 5.0 |
| 3y average | 999 | -34.87 | -18.85 | -32.51 | 3.3 |
| 5y average | 999 | -37.01 | -18.66 | -40.38 | 3.3 |
| Weighted average score | 3.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |